| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Lisinopril | Lisinopril EP Impurity A | VL600006 | View CAS 1012-05-1 |
| Lisinopril | Lisinopril EP Impurity B | VL600003 | View CAS 6192-52-5 |
| Lisinopril | Lisinopril EP Impurity C | VL600004 | View CAS 328385-86-0 |
| Lisinopril | Lisinopril EP Impurity D | VL600005 | View CAS 219677-82-4 |
| Lisinopril | Lisinopril EP Impurity D (Mixture of Diastereomers) | VE009495 | View CAS 1092813-99-4 |
| Lisinopril | Lisinopril EP Impurity E | VL600001 | View CAS 85955-59-5 |
| Lisinopril | Lisinopril EP Impurity F | VL600002 | View CAS 1132650-67-9 |
| Lisinopril | Lisinopril EP Impurity G | VE005896 | View CAS 1356839-89-8 |
| Lisinopril | Lisinopril EP Impurity H | VL600011 | View CAS 138247-43-5 |
| Lisinopril | Lisinopril EP Impurity I | VL600010 | View CAS 927819-64-5 |
| Lisinopril | Lisinopril epimer | VE009468 | View |
| Lisinopril | (S)-1-((S)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-6-(2, 2, 2-trifluoroacetamido)hexanoyl)pyrrolidine-2-carboxylic acid | VE0010250 | View CAS 103300-91-0 |
